Directory

>

Katy Barglow

avatar

Katy Barglow

Senior Vice President | 4D Molecular Therapeutics

Walnut Creek, California, United States

View contact details (it's free)

Katy Barglow

Summary

Katy Barglow is a highly accomplished CMC leader in the gene therapy sector, currently serving as the Senior Vice President of Technical Operations at 4D Molecular Therapeutics. With a robust background in biochemistry and molecular biology, she has spearheaded critical advancements in process development and clinical manufacturing of AAV gene therapies. Katy's expertise extends to analytical development, quality control, and regulatory strategy, showcasing her ability to navigate complex CMC requirements for pre-clinical and clinical products. She has a track record of driving innovation and efficiency in laboratory settings, evidenced by her contributions to assay development and process optimization. Her publication record reflects her commitment to advancing scientific understanding in proteomics and enzymology. Katy's leadership experience is complemented by her hands-on approach to project management and team development, making her a pivotal figure in her organization. She holds a PhD in Biochemistry and has been instrumental in fostering collaborations that bridge academia and industry.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Katy Barglow

Work Experience

company logo

Senior Vice President at

4D Molecular Therapeutics

January 2022 - Present

company logo

Vice President Technical Operations at

4D Molecular Therapeutics

January 2021 - March 2022

company logo

Vice President, Process and Analytical Developmen at

4D Molecular Therapeutics

January 2019 - January 2021

company logo

Director, Process Sciences and Analytical Development at

4D Molecular Therapeutics

June 2017 - January 2019

company logo

Analytical Group Leader at

Grifols

August 2014 - June 2017

company logo

Research Scientist II at

Baxter International Inc.

August 2012 - August 2014

💼

Temporary Research Scientist at

Dophen Biomedical

June 2012 - August 2012

company logo

Staff Scientist I at

Catalyst Biosciences

August 2011 - May 2012

company logo

Postdoctoral Fellow at

The University California Berkeley

July 2008 - August 2011

company logo

Graduate Student at

The Scripps Research Institute

September 2002 - June 2008

Logos provided by Logo.dev

Katy Barglow

Education

University of California, Berkeley, Postdoctoral Fellow

January 2008 - January 2011

The Scripps Research Institute, Doctor Of Philosophy (Phd)

January 2002 - January 2008

Stanford University, B.S

January 1998 - January 2002

Frequently Asked Questions about Katy Barglow

What is Katy Barglow email address?

Katy Barglow's primary email address is ************@grifols.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Katy Barglow work for?

Katy Barglow is a Senior Vice President at 4D Molecular Therapeutics, a company specializing in Commercial physical research.

Where Katy Barglow graduated from?

Katy Barglow holds a degree in from University of California, Berkeley.

How can I directly contact Katy Barglow?

To contact Katy Barglow directly, you can use the email address ************@grifols.com. Complete contact information is available upon registration with Muraena.

Who is Katy Barglow?

Katy Barglow is a highly accomplished CMC leader in the gene therapy sector, currently serving as the Senior Vice President of Technical Operations at 4D Molecular Therapeutics. With a robust background in biochemistry and molecular biology, she has spearheaded critical advancements in process development and clinical manufacturing of AAV gene therapies. Katy's expertise extends to analytical development, quality control, and regulatory strategy, showcasing her ability to navigate complex CMC requirements for pre-clinical and clinical products. She has a track record of driving innovation and efficiency in laboratory settings, evidenced by her contributions to assay development and process optimization. Her publication record reflects her commitment to advancing scientific understanding in proteomics and enzymology. Katy's leadership experience is complemented by her hands-on approach to project management and team development, making her a pivotal figure in her organization. She holds a PhD in Biochemistry and has been instrumental in fostering collaborations that bridge academia and industry.

Katy`s contact details

mail

************@grifols.com

********@berkeley.edu

********@4dmoleculartherapeutics.com

Colleagues

avatar
Scott Bizily

Chief Legal Officer

avatar
Theresa Janke

Chief Of Staff

avatar
Alan Cohen Md

Senior Vice President - Clinical Development, Therapeutic Area Head - Pulmonology

avatar
An Song

Chief Research & Translational Development Officer

avatar
Robert Kim

Chief Medical Officer

Kim Maplestone

SVP, Clinical Development Operations

avatar
Shawn Tomasello

Board Member

avatar
Melissa Calton

Vice President, Early-Stage Product Development

avatar
Angela Arafelis

Executive Business Partner, CEO Office

avatar
David Kirn Md

Co-Founder & Board Director: Life Sciences Entrepreneurship Center

View Contact details (it's free)
Request Profile Removal